Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.48 |
| ▸ | TSHR | P16473 | 1/20 | 0.48 |
| ▸ | APP | P05067 | 1/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.42 |
| ▸ | PDE4A | P27815 | 1/20 | 0.42 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | SLC6A6 | P31641 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 2/20 | 0.36 |
| ▸ | THRA | P10827 | 1/20 | 0.36 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | KDM4A | O75164 | 6/20 | 0.34 |
| ▸ | KDM4C | Q9H3R0 | 6/20 | 0.34 |
| ▸ | KDM5A | P29375 | 1/20 | 0.34 |
| ▸ | KDM7A | Q6ZMT4 | 1/20 | 0.34 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.34 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17655619 | 0.98 | ALDH1A1 (0.52) | ALDH1A1TSHRAPPPTGS1PDE4A | |
| Sulfuric Acid SCHEMBL29054592 | 0.98 | ALDH1A1 (0.46) | ALDH1A1TSHRAPPPTGS1PDE4A | |
| SCHEMBL2923686 | 0.98 | ALDH1A1 (0.52) | ALDH1A1TSHRAPPPTGS1PDE4A | |
| SCHEMBL128907 | 0.92 | APP (0.46) | ALDH1A1TSHRAPPPTGS1PDE4A | |
| Water SCHEMBL21226523 | 0.90 | APP (0.44) | ALDH1A1TSHRAPPPTGS1PDE4A | |
| SCHEMBL5017073 | 0.90 | APP (0.44) | ALDH1A1TSHRAPPPTGS1PDE4A | |
| Hydrochloric Acid SCHEMBL3148714 | 0.90 | APP (0.44) | ALDH1A1TSHRAPPPTGS1PDE4A | |
| SCHEMBL10653894 | 0.89 | DNM1 (0.60) | ALDH1A1TSHRDNM1THRBTHRA | |
| Dymanthine SCHEMBL10655424 | 0.89 | DNM1 (0.60) | ALDH1A1TSHRDNM1THRBTHRA | |
| SCHEMBL5605734 | 0.89 | DNM1 (0.60) | ALDH1A1TSHRDNM1THRBTHRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2279192-B1 | IONIC LIQUIDS | MERCK PATENT GMBH (DE) | 2013-10-30 | — | — | EP | claimed |
| EP-2025743-B1 | Hard surface cleaning compostion | PROCTER & GAMBLE (US) | 2011-04-13 | — | — | EP | claimed |
| US-7670798-B2 | Automated method and reagent therefor assaying body fluid samples such as cerebrospinal fluid (CSF) | SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) | 2010-03-02 | — | — | US | claimed |
| US-20030215890-A1 | Automated method and reagent therefor assaying body fluid samples such as cerebrospinal fluid (CSF) | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 2003-11-20 | — | — | US | claimed |
| US-6468732-B1 | CROSSLINKER- FREE REAGENT; SODIUM BICARBONATE AND A SPHERING SURFACTANT | BAYER CORPORATION | 2002-10-22 | — | — | US | claimed |
| EP-0878715-B1 | Cyanide-containing hemoglobin reagent composition and method providing acceptable precision, accuracy and freedom from white cell interference on automated hematology analyzers | BAYER AG (US) | 2002-07-31 | — | — | EP | claimed |
| US-5858794-A | MIXTURE CONTAINING SURFACTANT AND PH BUFFER | BAYER CORPORATION (US) | 1999-01-12 | — | — | US | claimed |
| EP-0878715-A1 | Cyanide-containing hemoglobin reagent composition and method providing acceptable precision, accuracy and freedom from white cell interference on automated hematology analyzers | Bayer Corporation (US) | 1998-11-18 | — | — | EP | claimed |
| EP-4719328-A1 | BLEACHING MEDIUM COMPRISING A PHENALENONE | Wella Germany GmbH (DE) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024246147-A1 | BLEACHING MEDIUM COMPRISING A PHENALENONE | WELLA GERMANY GMBH (DE) | 2024-12-05 | — | — | WO | disclosed |
| CN-107108486-B | Process for producing specific acetals and ketals | 帝斯曼知识产权资产管理有限公司 | 2023-06-02 | — | — | CN | disclosed |
| US-11389550-B2 | Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound | RIKEN (JP) | 2022-07-19 | — | — | US | disclosed |
| WO-2021068950-A1 | AMIDE COMPOUND AND MEDICAL USE THEREOF AS STING INHIBITOR | 中国药科大学 | 2021-04-15 | — | — | WO | disclosed |
| CN-108017610-B | Preparation method of vitamin E | 浙江新和成药业有限公司 | 2020-11-06 | — | — | CN | disclosed |
| EP-1376135-A2 | Automated method and reagent therefor for assaying body fluid samples such as cerebrospinal fluid | BAYER CORPORATION (US) | 2004-01-02 | — | — | EP | disclosed |
| US-20030215890-A1 | Automated method and reagent therefor assaying body fluid samples such as cerebrospinal fluid (CSF) | SIEMENS HEALTHCARE DIAGNOSTICS INC. | 2003-11-20 | — | — | US | disclosed |
| US-6468732-B1 | CROSSLINKER- FREE REAGENT; SODIUM BICARBONATE AND A SPHERING SURFACTANT | BAYER CORPORATION | 2002-10-22 | — | — | US | disclosed |
| EP-0878715-B1 | Cyanide-containing hemoglobin reagent composition and method providing acceptable precision, accuracy and freedom from white cell interference on automated hematology analyzers | BAYER AG (US) | 2002-07-31 | — | — | EP | disclosed |
| US-5858794-A | MIXTURE CONTAINING SURFACTANT AND PH BUFFER | BAYER CORPORATION (US) | 1999-01-12 | — | — | US | disclosed |
| EP-0878715-A1 | Cyanide-containing hemoglobin reagent composition and method providing acceptable precision, accuracy and freedom from white cell interference on automated hematology analyzers | Bayer Corporation (US) | 1998-11-18 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11389550-B2 | Nanoparticle, contrast agent for magnetic resonance imaging containing same, and ligand compound | TFRC, AIFM2, SFXN3 | ALDH1A1 4125/4885TSHR 2348/4885APP 1268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.